Darwin Wealth Management’s Medline Inc MDLN Stock Holding History

Darwin Wealth Management’s Portfolio MDLN Stock Details MDLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$91	Buy	+2	New	+$73	﹤0.01%	1142

Other funds holding MDLN

Carlyle Group Washington, District of Columbia $8.36B AUM 14.46% 1-Year Est. Return

H&F Corporate Investors X San Francisco, California $2.46B AUM 15.37% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Egerton Capital (UK) London, United Kingdom $9.8B AUM 22.76% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $106B AUM 2.29% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Banque Pictet & Cie Geneva 73, Switzerland $14.5B AUM 33.71% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $64.1B AUM 28.9% 1-Year Est. Return

Darwin Wealth Management's MDLN Position: Q3 2026 in Review

Darwin Wealth Management opened a new position in Medline Inc (MDLN) in Q3 2026: 2 shares worth $91. The stake represents ﹤0.01% of the portfolio and ranks #1142 among its holdings.

214 funds tracked by Wall St. Rank hold MDLN as of Q3 2026.

Darwin Wealth Management held 2 shares of Medline Inc worth $91 as of Q3 2026.
Medline Inc was a new Darwin Wealth Management position in Q3 2026.
Medline Inc made up ﹤0.01% of Darwin Wealth Management's portfolio in Q3 2026, its #1142 holding.
214 funds tracked by Wall St. Rank held Medline Inc as of Q3 2026.

Based on Darwin Wealth Management's 13F filing for Q3 2026, filed 9 Nov 2026.